AU1580001A - Process for the preparation of aryloxy propanolamines - Google Patents
Process for the preparation of aryloxy propanolaminesInfo
- Publication number
- AU1580001A AU1580001A AU15800/01A AU1580001A AU1580001A AU 1580001 A AU1580001 A AU 1580001A AU 15800/01 A AU15800/01 A AU 15800/01A AU 1580001 A AU1580001 A AU 1580001A AU 1580001 A AU1580001 A AU 1580001A
- Authority
- AU
- Australia
- Prior art keywords
- preparation
- propanolamines
- aryloxy
- aryloxy propanolamines
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16559499P | 1999-11-15 | 1999-11-15 | |
US60165594 | 1999-11-15 | ||
PCT/US2000/030128 WO2001036412A1 (en) | 1999-11-15 | 2000-11-13 | Process for the preparation of aryloxy propanolamines |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1580001A true AU1580001A (en) | 2001-05-30 |
Family
ID=22599580
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU15800/01A Abandoned AU1580001A (en) | 1999-11-15 | 2000-11-13 | Process for the preparation of aryloxy propanolamines |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU1580001A (en) |
PE (1) | PE20010702A1 (en) |
WO (1) | WO2001036412A1 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003514801A (en) | 1999-11-15 | 2003-04-22 | イーライ・リリー・アンド・カンパニー | Indazolyloxypropanolamine for improving livestock production |
JP2004513164A (en) | 2000-11-10 | 2004-04-30 | イーライ・リリー・アンド・カンパニー | 3-substituted oxindole β3 agonist |
ES2262817T3 (en) | 2001-08-14 | 2006-12-01 | Eli Lilly And Company | BETA-3 OXINDOL 3-SUBSTITUTED AGONISTS. |
EP1421078B1 (en) | 2001-08-14 | 2006-09-27 | Eli Lilly And Company | Indole derivatives as beta-3 adrenergic agonists for the treatment of type 2 diabetes |
AU2002347982A1 (en) | 2001-11-20 | 2003-06-10 | Eli Lilly And Company | 3-SUBSTITUTED OXINDOLE Beta3 AGONISTS |
EP1448561B1 (en) | 2001-11-20 | 2008-02-20 | Eli Lilly And Company | Beta 3 adrenergic agonists |
WO2003059348A1 (en) * | 2002-01-11 | 2003-07-24 | Eli Lilly And Company | 2-oxo-benzimidazolyl substituted ethanolamine derivatives and their use as beta3 agonists |
EP2903452A1 (en) | 2012-10-02 | 2015-08-12 | Eli Lilly and Company | Methods for improving chicken production |
CN115611752A (en) * | 2022-10-21 | 2023-01-17 | 江苏天和制药有限公司 | Synthetic refining method of lubabylon intermediate |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH624395A5 (en) * | 1976-01-08 | 1981-07-31 | Ciba Geigy Ag | |
GB1574665A (en) * | 1976-05-08 | 1980-09-10 | Otsuka Pharma Co Ltd | 3,4-dihydrocarbostyril derivatives and process for preparing the same |
CH607585A5 (en) * | 1976-10-05 | 1978-09-15 | Ciba Geigy Ag | Process for the preparation of 2-[3'-(2-(3,4-dimethoxy-phenyl)ethylamino)-2'-hydroxypropoxy]-3-cyanop yridine |
DE2830211A1 (en) * | 1977-07-21 | 1979-02-01 | Sandoz Ag | SUBSTITUTED INDOL DERIVATIVES, THEIR PRODUCTION AND USE |
KR19990045727A (en) * | 1995-09-21 | 1999-06-25 | 피터 지. 스트링거 | Selective β3 Adrenaline Agonists |
ZA967892B (en) * | 1995-09-21 | 1998-03-18 | Lilly Co Eli | Selective β3 adrenergic agonists. |
DE69711519T2 (en) * | 1996-09-05 | 2002-10-31 | Lilly Co Eli | Carbazole analogues as selective beta3-adrenergic agonists |
US5808080A (en) * | 1996-09-05 | 1998-09-15 | Eli Lilly And Company | Selective β3 adrenergic agonists |
CO5011072A1 (en) * | 1997-12-05 | 2001-02-28 | Lilly Co Eli | ETANOLAMINAS PIRAZINIL SUBSTITUTED AS AGFONISTS OF THE RECEPTORS |
-
2000
- 2000-11-13 AU AU15800/01A patent/AU1580001A/en not_active Abandoned
- 2000-11-13 WO PCT/US2000/030128 patent/WO2001036412A1/en active Application Filing
- 2000-11-15 PE PE2000001222A patent/PE20010702A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2001036412A1 (en) | 2001-05-25 |
PE20010702A1 (en) | 2001-07-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6107399A (en) | Process for the preparation of ethyl acetate | |
AU1055701A (en) | Process for the preparation of diol mixtures | |
AU7902400A (en) | Method for the preparation of 5-carboxyphthalide | |
AU2001273762A1 (en) | Process for the preparation of (r)-2-alkyl-3-phenyl-1-propanols | |
AU2002238421A1 (en) | Process for the preparation of phenethylamine derivatives | |
AU7972200A (en) | Process for the preparation of urea | |
AU2466700A (en) | Process for the preparation of urea | |
AU6123099A (en) | Process for the preparation of amine derivatives | |
AU1580001A (en) | Process for the preparation of aryloxy propanolamines | |
AU1434301A (en) | Process for the preparation of sulfamides | |
AU2982000A (en) | Preparation of 9-hydrocarbyl-9-phosphabicyclononanes | |
AU2943400A (en) | Process for the preparation of alpha-aminoketone derivatives | |
AU2829700A (en) | Processes for the preparation of alpha-aminoketones | |
AU4134600A (en) | Process for the preparation of calanolide precursors | |
AU8627798A (en) | Biocatalytic process for the preparation of 3-0-acyl-flavonoids | |
AU7958000A (en) | Process for the preparation of oxyiminoalkanoic acid derivatives | |
HUP0202865A3 (en) | Process for the preparation of 2-cyanopyridines | |
IL138691A (en) | Process for the preparation of 3-acyl-indoles | |
AU4151700A (en) | Process for the preparation of caprolactam | |
HUP0203384A3 (en) | Process for the preparation of ketimines | |
AU2155501A (en) | Process for the preparation of ketimines | |
AU6870500A (en) | Process for the preparation of 2,3-dihydroazepine derivatives | |
AU7306100A (en) | A stereoselective process for the preparation of endo-3-aminoazabicycloalkanes | |
AU1601801A (en) | Methods of preparing crna | |
AU6870600A (en) | Process for the preparation of 2,3-dihydroazepine compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |